Related Experiment Videos
Amyloid beta-peptide(25-35) changes [Ca2+] in hippocampal neurons
H S Mogensen1, D M Beatty, S J Morris
1Department of Pharmacology, University of Copenhagen, Denmark.
Neuroreport
|June 19, 1998
Summary
Amyloid beta-peptide (A beta) aggregates in Alzheimer disease (AD) brains increase intracellular calcium ([Ca2+]i). This study shows A beta(25-35) exposure in neurons elevates both [Ca2+]i and intracellular acidity.
Area of Science:
- Neuroscience
- Biochemistry
- Cell Biology
Background:
- Amyloid beta-peptide (A beta) aggregates form senile plaques in Alzheimer disease (AD) brains.
- Aggregated A beta is linked to increased intracellular calcium ([Ca2+]i), a hallmark of neuronal dysfunction.
- Understanding A beta's impact on neuronal ion concentrations is crucial for AD research.
Purpose of the Study:
- To investigate the effects of A beta(25-35) on intracellular calcium ([Ca2+]i) and intracellular pH ([H+]i) in hippocampal neurons.
- To determine if A beta exposure alters neuronal ion homeostasis.
Main Methods:
- Utilized real-time fluorescence imaging techniques.
- Employed indo-1 and SNARF-1 dyes for specific measurement of [Ca2+]i and [H+]i.
- Examined single hippocampal neurons in vitro.
Main Results:
- Incubation with A beta(25-35) for 3-12 days significantly increased [Ca2+]i in neurons.
- A beta(25-35) exposure also led to an increase in intracellular acidity ([H+]i).
- These effects were observed in large, NMDA-responsive neurons.
Conclusions:
- A beta(25-35) exposure disrupts normal intracellular calcium and pH balance in hippocampal neurons.
- This disruption may contribute to the neurotoxic effects observed in Alzheimer disease.
- Further research is needed to elucidate the precise mechanisms of A beta-induced ion dysregulation.